VAN ECK ASSOCIATES CORP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 869178
NEW YORK, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,941,583
-$4,191,891 QoQ
Shares Held
1,356,009
-18.5% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#72
of 671 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $463,988,771 across 11 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,252,140 | $305,558,778 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,356,009 | $45,941,583 | |
| 3 | HLN |
Haleon plc
|
3,095,451 | $28,880,557 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,674,005 | $26,834,300 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
707,194 | $17,404,044 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
29,023 | $15,725,531 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
69,482 | $11,710,496 | |
| 8 | VTRS |
Viatris Inc
|
644,514 | $10,234,881 |
All Filings in TEVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,941,583 | 1,356,009 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,133,474 | 1,664,458 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $47,253,937 | 1,514,064 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $18,945,701 | 937,906 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,524,338 | 1,045,605 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $35,672,109 | 2,320,892 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,609,917 | 1,615,695 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $33,794,473 | 1,875,387 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $27,084,101 | 1,666,714 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $21,827,944 | 1,546,984 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $20,279,093 | 1,942,442 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $23,114,107 | 2,266,089 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $19,325,156 | 2,566,422 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $14,812,421 | 1,673,720 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $24,105,071 | 2,643,100 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $18,516,146 | 2,294,442 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $24,167,279 | 3,213,734 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $17,735,671 | 1,888,783 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $15,317,730 | 1,912,326 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $15,655,315 | 1,607,322 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $12,049,705 | 1,217,142 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $9,378,084 | 812,659 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $10,270,330 | 1,064,283 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $10,787,537 | 1,197,285 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $10,863,765 | 881,084 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $8,343,264 | 929,094 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||